The CRO concept continued to be strong, with Baihua Pharmaceutical rising more than 10% in a row, and Kangming Kangde, Gloria Ying, Zhaoyan New Pharmaceutical, Kanglong Chemical, and Innox followed suit.

Zhitongcaijing · 2d ago
The CRO concept continued to be strong, with Baihua Pharmaceutical rising more than 10% in a row, and Kangming Kangde, Gloria Ying, Zhaoyan New Pharmaceutical, Kanglong Chemical, and Innox followed suit.